VRPX
Virpax Pharmaceuticals Inc

6,333
Loading...
Loading...
News
all
press releases
Virpax Confirms Positive Results with US Army with Probudur for Combat Care Study
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...
Business Wire·7mo ago
News Placeholder
More News
News Placeholder
Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...
Business Wire·8mo ago
News Placeholder
Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain indications...
Business Wire·8mo ago
News Placeholder
Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain indications...
Business Wire·8mo ago
News Placeholder
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...
Business Wire·10mo ago
News Placeholder
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a company specializing in developing pharmaceutical products for pain management, announced that it has been granted an extension...
Business Wire·10mo ago
News Placeholder
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain indications...
Business Wire·10mo ago
News Placeholder
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (Virpax or the Company), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain indications...
Business Wire·10mo ago
News Placeholder
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
Virpax Pharmaceuticals, Inc. (Virpax or the Company) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...
Business Wire·1y ago
News Placeholder
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
Virpax Pharmaceuticals, Inc. (Virpax or the Company) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...
Business Wire·1y ago

Latest VRPX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.